ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,197 | -20.4% | 778 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $6,527 | +82.1% | 778 | +115.5% | 0.00% | – |
Q1 2023 | $3,585 | +0.6% | 361 | -29.5% | 0.00% | – |
Q4 2022 | $3,564 | -10.9% | 512 | -32.7% | 0.00% | -100.0% |
Q3 2022 | $4,000 | +33.3% | 761 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | 0.0% | 761 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -70.0% | 761 | -70.1% | 0.00% | -100.0% |
Q4 2021 | $10,000 | -37.5% | 2,541 | -15.3% | 0.00% | -66.7% |
Q3 2019 | $16,000 | -11.1% | 3,000 | 0.0% | 0.01% | -14.3% |
Q2 2019 | $18,000 | – | 3,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,015,668 | $25,301,454 | 30.67% |
Perceptive Advisors | 11,350,085 | $95,227,213 | 2.76% |
JOHNSON & JOHNSON | 394,834 | $3,312,657 | 1.03% |
Affinity Asset Advisors, LLC | 150,000 | $1,258,500 | 0.44% |
Prosight Management, LP | 299,022 | $2,508,794 | 0.38% |
Tri Locum Partners LP | 73,067 | $613,032 | 0.23% |
WOODSTOCK CORP | 137,179 | $1,150,932 | 0.14% |
Joseph P. Lucia & Associates, LLC | 22,781 | $191,133 | 0.13% |
Palo Alto Investors LP | 160,800 | $1,349,112 | 0.11% |
Verition Fund Management LLC | 930,074 | $7,803,321 | 0.10% |